SHIONOGI & CO LTD

JP3347200002 · 4507.T (JPX)

0 value funds · 5 CNMV managers

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Healthcare · Drug Manufacturers - Specialty & Generic
https://www.shionogi.com

Value funds holding it

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →

CNMV managers

3 → 5 (+2) · net presence change vs. previous period

See context in Radar Gestoras →

Funds (CNMV universe)

3 → 6 (+3) · net presence change vs. previous period

Avg. weight

0.56%

Price

2934.00 JPY

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CNMV data · half-year closed 2025-12-31.

Price for 4507.T (JPX), updated 2026-10-18. Source: Yahoo Finance.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Fund Manager Weight

MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. 1.98% KUTXABANK BOLSA JAPON, FI KUTXABANK GESTION, SGIIC, S.A. 0.55% IBERCAJA JAPON, FI IBERCAJA GESTION, SGIIC, S.A. 0.49% BBVA BOLSA INDICE JAPON (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC 0.29% INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. 0.01% INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. 0.01%

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 3 Exits: 0 Increasing exposure: 0 Reducing exposure: 1

+ INVERSABADELL 25, FI

Enters the position at 0.01% weight.

+ INVERSABADELL 50, FI

Enters the position at 0.01% weight.

+ IBERCAJA JAPON, FI

Enters the position at 0.49% weight.

Objective ratios

FCF yield

-0.2%

Net debt / EBITDA

2.56x

P/E

—

52-week range

2392.50 – 3758.00 JPY

Data as-is, not an interpretation: it does not say whether the price is cheap or expensive, and it is not a buy or sell recommendation.

Updated 2026-09-06. Source: Yahoo Finance.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.